374 related articles for article (PubMed ID: 29347850)
1. Feasibility of electrospray deposition for rapid screening of the cocrystal formation and single step, continuous production of pharmaceutical nanococrystals.
Emami S; Siahi-Shadbad M; Barzegar-Jalali M; Adibkia K
Drug Dev Ind Pharm; 2018 Jun; 44(6):1034-1047. PubMed ID: 29347850
[TBL] [Abstract][Full Text] [Related]
2. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
Basavoju S; Boström D; Velaga SP
Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
[TBL] [Abstract][Full Text] [Related]
5. pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.
Alhalaweh A; Roy L; Rodríguez-Hornedo N; Velaga SP
Mol Pharm; 2012 Sep; 9(9):2605-12. PubMed ID: 22867056
[TBL] [Abstract][Full Text] [Related]
6. Green production of cocrystals using a new solvent-free approach by spray congealing.
Duarte Í; Andrade R; Pinto JF; Temtem M
Int J Pharm; 2016 Jun; 506(1-2):68-78. PubMed ID: 27073084
[TBL] [Abstract][Full Text] [Related]
7. Thermal analysis and FTIR spectral curve-fitting investigation of formation mechanism and stability of indomethacin-saccharin cocrystals via solid-state grinding process.
Zhang GC; Lin HL; Lin SY
J Pharm Biomed Anal; 2012 Jul; 66():162-9. PubMed ID: 22497855
[TBL] [Abstract][Full Text] [Related]
8. Small-Scale Assays for Studying Dissolution of Pharmaceutical Cocrystals for Oral Administration.
Box KJ; Comer J; Taylor R; Karki S; Ruiz R; Price R; Fotaki N
AAPS PharmSciTech; 2016 Apr; 17(2):245-51. PubMed ID: 26208438
[TBL] [Abstract][Full Text] [Related]
9. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.
Boksa K; Otte A; Pinal R
J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421
[TBL] [Abstract][Full Text] [Related]
10. Powder X-ray diffraction method for the quantification of cocrystals in the crystallization mixture.
Padrela L; de Azevedo EG; Velaga SP
Drug Dev Ind Pharm; 2012 Aug; 38(8):923-9. PubMed ID: 22092083
[TBL] [Abstract][Full Text] [Related]
11. Formation of Indomethacin-Saccharin Cocrystals during Wet Granulation: Role of Polymeric Excipients.
Tanaka R; Duggirala NK; Hattori Y; Otsuka M; Suryanarayanan R
Mol Pharm; 2020 Jan; 17(1):274-283. PubMed ID: 31756100
[TBL] [Abstract][Full Text] [Related]
12. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
[TBL] [Abstract][Full Text] [Related]
13. SpeedMixing: Rapid Tribochemical Synthesis and Discovery of Pharmaceutical Cocrystals without Milling or Grinding Media.
Teoh Y; Ayoub G; Huskić I; Titi HM; Nickels CW; Herrmann B; Friščić T
Angew Chem Int Ed Engl; 2022 Oct; 61(41):e202206293. PubMed ID: 35894150
[TBL] [Abstract][Full Text] [Related]
14. The role of the polymer matrix in solvent-free hot melt extrusion continuous process for mechanochemical synthesis of pharmaceutical cocrystal.
Gajda M; Nartowski KP; Pluta J; Karolewicz B
Eur J Pharm Biopharm; 2018 Oct; 131():48-59. PubMed ID: 30205892
[TBL] [Abstract][Full Text] [Related]
15. Kinetics Study of Cocrystal Formation Between Indomethacin and Saccharin Using High-Shear Granulation With In Situ Raman Spectroscopy.
Tanaka R; Hattori Y; Ashizawa K; Otsuka M
J Pharm Sci; 2019 Oct; 108(10):3201-3208. PubMed ID: 31279736
[TBL] [Abstract][Full Text] [Related]
16. Coformer selection based on degradation pathway of drugs: a case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-nicotinamide cocrystals.
Gao Y; Gao J; Liu Z; Kan H; Zu H; Sun W; Zhang J; Qian S
Int J Pharm; 2012 Nov; 438(1-2):327-35. PubMed ID: 22989978
[TBL] [Abstract][Full Text] [Related]
17. Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds.
Shiraki K; Takata N; Takano R; Hayashi Y; Terada K
Pharm Res; 2008 Nov; 25(11):2581-92. PubMed ID: 18651208
[TBL] [Abstract][Full Text] [Related]
18. HPLC determination of olanzapine and carbamazepine in their nicotinamide cocrystals and investigation of the dissolution profiles of cocrystal tablet formulations.
Renkoğlu P; Çelebier M; Arıca-Yegin B
Pharm Dev Technol; 2015 May; 20(3):380-4. PubMed ID: 24521464
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of indomethacin-saccharin cocrystals.
Jung MS; Kim JS; Kim MS; Alhalaweh A; Cho W; Hwang SJ; Velaga SP
J Pharm Pharmacol; 2010 Nov; 62(11):1560-8. PubMed ID: 21039541
[TBL] [Abstract][Full Text] [Related]
20. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]